249 related articles for article (PubMed ID: 30022368)
1. Do SNPs in folate pharmacokinetic pathway alter levels of intracellular methotrexate polyglutamates and affect response? A prospective study in Indian patients.
Sandhu A; Ahmad S; Kaur J; Bhatnagar A; Dhawan V; Dhir V
Clin Rheumatol; 2018 Dec; 37(12):3221-3228. PubMed ID: 30022368
[TBL] [Abstract][Full Text] [Related]
2. Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients.
van der Straaten RJ; Wessels JA; de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Allaart CF; Bogaartz J; Tiller M; Huizinga TW; Guchelaar HJ
Pharmacogenomics; 2007 Feb; 8(2):141-50. PubMed ID: 17286537
[TBL] [Abstract][Full Text] [Related]
3. Folyl polyglutamate synthethase (FPGS) gene polymorphisms may influence methotrexate adverse events in South Indian Tamil Rheumatoid Arthritis patients.
Muralidharan N; Sundaram R; Kodidela S; Chengappa KG; Mariaselvam CM; Misra DP; Negi VS
Pharmacogenomics J; 2020 Apr; 20(2):342-349. PubMed ID: 31611592
[TBL] [Abstract][Full Text] [Related]
4. Contribution of common polymorphisms in reduced folate carrier and gamma-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis.
Dervieux T; Kremer J; Lein DO; Capps R; Barham R; Meyer G; Smith K; Caldwell J; Furst DE
Pharmacogenetics; 2004 Nov; 14(11):733-9. PubMed ID: 15564880
[TBL] [Abstract][Full Text] [Related]
5. Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis.
Davis LA; Polk B; Mann A; Wolff RK; Kerr GS; Reimold AM; Cannon GW; Mikuls TR; Caplan L
Clin Exp Rheumatol; 2014; 32(3):324-32. PubMed ID: 24447348
[TBL] [Abstract][Full Text] [Related]
6. Folylpolyglutamate synthase is a major determinant of intracellular methotrexate polyglutamates in patients with rheumatoid arthritis.
Yamamoto T; Shikano K; Nanki T; Kawai S
Sci Rep; 2016 Oct; 6():35615. PubMed ID: 27752107
[TBL] [Abstract][Full Text] [Related]
7. Sex Differences in mRNA Expression of Reduced Folate Carrier-1, Folypolyformyl Glutamate Synthase, and γ-Glutamyl Hydrolase in a Healthy Japanese Population.
Hashiguchi M; Tanaka T; Shimizu M; Tsuru T; Chiyoda T; Miyawaki K; Irie S; Takeuchi O; Hakamata J; Mochizuki M
J Clin Pharmacol; 2016 Dec; 56(12):1563-1569. PubMed ID: 27146084
[TBL] [Abstract][Full Text] [Related]
8. Reduced folate carrier-1 80G > A gene polymorphism is not associated with methotrexate treatment response in South Indian Tamils with rheumatoid arthritis.
Muralidharan N; Mariaselvam CM; Mithun CB; Negi VS
Clin Rheumatol; 2016 Apr; 35(4):879-85. PubMed ID: 25771854
[TBL] [Abstract][Full Text] [Related]
9. A substrate specific functional polymorphism of human gamma-glutamyl hydrolase alters catalytic activity and methotrexate polyglutamate accumulation in acute lymphoblastic leukaemia cells.
Cheng Q; Wu B; Kager L; Panetta JC; Zheng J; Pui CH; Relling MV; Evans WE
Pharmacogenetics; 2004 Aug; 14(8):557-67. PubMed ID: 15284538
[TBL] [Abstract][Full Text] [Related]
10. Influence of genetic polymorphisms of FPGS, GGH, and MTHFR on serum methotrexate levels in Chinese children with acute lymphoblastic leukemia.
Wang SM; Sun LL; Zeng WX; Wu WS; Zhang GL
Cancer Chemother Pharmacol; 2014 Aug; 74(2):283-9. PubMed ID: 24908438
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients.
Moya P; Salazar J; Arranz MJ; Díaz-Torné C; del Río E; Casademont J; Corominas H; Baiget M
Pharmacogenomics; 2016; 17(1):25-9. PubMed ID: 26652611
[TBL] [Abstract][Full Text] [Related]
12. Association of the TYMS 3G/3G genotype with poor response and GGH 354GG genotype with the bone marrow toxicity of the methotrexate in RA patients.
Jekic B; Lukovic L; Bunjevacki V; Milic V; Novakovic I; Damnjanovic T; Milasin J; Popovic B; Maksimovic N; Damjanov N; Radunovic G; Kovacevic L; Krajinovic M
Eur J Clin Pharmacol; 2013 Mar; 69(3):377-83. PubMed ID: 22763757
[TBL] [Abstract][Full Text] [Related]
13. Clinico-genetic model to predict methotrexate intolerance in rheumatoid arthritis.
Sandhu A; Dhir V; Ahmad S; Dhawan V; Kaur J; Bhatnagar A
Clin Rheumatol; 2020 Jan; 39(1):201-206. PubMed ID: 31522319
[TBL] [Abstract][Full Text] [Related]
14. High Methotrexate Triglutamate Level Is an Independent Predictor of Adverse Effects in Asian Indian Rheumatoid Arthritis Patients-A Preliminary Study.
Sandhu A; Dhir V; Bhatnagar A; Dhawan V; Kaur J; Sood A; Naidu S; Ahmad S; Varma N; Sharma A; Sharma S
Ther Drug Monit; 2017 Apr; 39(2):157-163. PubMed ID: 28107255
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in metabolic and cellular transport pathway of methotrexate impact clinical outcome of methotrexate monotherapy in Japanese patients with rheumatoid arthritis.
Kato T; Hamada A; Mori S; Saito H
Drug Metab Pharmacokinet; 2012; 27(2):192-9. PubMed ID: 22104130
[TBL] [Abstract][Full Text] [Related]
16. Impact of genetic variants of ATP binding cassette B1, AICAR transformylase/IMP cyclohydrolase, folyl-polyglutamatesynthetase, and methylenetetrahydrofolatereductase on methotrexate toxicity.
Sala-Icardo L; Lamana A; Ortiz AM; García Lorenzo E; Moreno Fresneda P; García-Vicuña R; González-Álvaro I
Reumatol Clin; 2017; 13(6):318-325. PubMed ID: 27751863
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation in folylpolyglutamate synthase and gamma-glutamyl hydrolase and plasma homocysteine levels in the Singapore Chinese Health Study.
Oppeneer SJ; Ross JA; Koh WP; Yuan JM; Robien K
Mol Genet Metab; 2012 Jan; 105(1):73-8. PubMed ID: 22018726
[TBL] [Abstract][Full Text] [Related]
18. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis.
Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M
Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736
[TBL] [Abstract][Full Text] [Related]
19. Determinants of erythrocyte methotrexate polyglutamate levels in rheumatoid arthritis.
den Boer E; de Rotte MC; Pluijm SM; Heil SG; Hazes JM; de Jonge R
J Rheumatol; 2014 Nov; 41(11):2167-78. PubMed ID: 25225283
[TBL] [Abstract][Full Text] [Related]
20. gamma-Glutamyl hydrolase and folylpolyglutamate synthetase activities predict polyglutamylation of methotrexate in acute leukemias.
Longo GS; Gorlick R; Tong WP; Lin S; Steinherz P; Bertino JR
Oncol Res; 1997; 9(5):259-63. PubMed ID: 9306433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]